Viridian Therapeutics, Inc. · NASDAQ:VRDN

Kynam Capital Management, LP reported a 1.54% stake in Viridian Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Kynam Capital Management, LP reported a 1.54% stake in Viridian Therapeutics, Inc., 1,470,541 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
1.54%
Shares
1,470,541
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Kynam Capital Management, LP1.54%1,470,541
Kynam Capital Management GP, LLC1.54%1,470,541
Yue Tang1.54%1,470,541

Source

View original at SEC

Related